Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma by Liu, Yuexin, Patel, Lalit, Mills, Gordon B, Lu, Karen H, Sood, Anil K, Ding, Li, Kucherlapati, Raju, Mardis, Elaine R, Levine, Douglas A, Shmulevich, Ilya, Broaddus, Russell R, Zhang, Wei

Get full text

C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancer by Li, Xi, Poire, Alfonso, Jeong, Kang Jin, Zhang, Dong, Ozmen, Tugba Yildiran, Chen, Gang, Sun, Chaoyang, Mills, Gordon B.

Get full text

Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations by Dogruluk, Turgut, Tsang, Yiu Huen, Espitia, Maribel, Chen, Fengju, Chen, Tenghui, Chong, Zechen, Appadurai, Vivek, Dogruluk, Armel, Eterovic, Agna Karina, Bonnen, Penelope E, Creighton, Chad J, Chen, Ken, Mills, Gordon B, Scott, Kenneth L

Get full text

Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer by McGrail, Daniel J., Garnett, Jeannine, Yin, Jun, Dai, Hui, Shih, David J.H., Lam, Truong Nguyen Anh, Li, Yang, Sun, Chaoyang, Li, Yongsheng, Schmandt, Rosemarie, Wu, Ji Yuan, Hu, Limei, Liang, Yulong, Peng, Guang, Jonasch, Eric, Menter, David, Yates, Melinda S., Kopetz, Scott, Lu, Karen H., Broaddus, Russell, Mills, Gordon B., Sahni, Nidhi, Lin, Shiaw-Yih

Get full text

Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma by Marusak, Charles, Thakur, Varsha, Li, Yuan, Freitas, Juliano T, Zmina, Patrick M, Thakur, Vijay S, Chang, Mayland, Gao, Ming, Tan, Jiufeng, Xiao, Min, Lu, Yiling, Mills, Gordon B, Flaherty, Keith, Frederick, Dennie T, Miao, Benchun, Sullivan, Ryan J, Moll, Tabea, Boland, Genevieve M, Herlyn, Meenhard, Zhang, Gao, Bedogni, Barbara

Get full text

Verteporfin inhibits YAP function through up-regulating 14-3-3σ sequestering YAP in the cytoplasm by Wang, Chao, Zhu, Xiaoyong, Feng, Weiwei, Yu, Yinhua, Jeong, Kangjin, Guo, Wei, Lu, Yiling, Mills, Gordon B

Get full text

RNA editing derived epitopes function as cancer antigens to elicit immune responses by Zhang, Minying, Fritsche, Jens, Roszik, Jason, Williams, Leila J., Peng, Xinxin, Chiu, Yulun, Tsou, Chih-Chiang, Hoffgaard, Franziska, Goldfinger, Valentina, Schoor, Oliver, Talukder, Amjad, Forget, Marie A., Haymaker, Cara, Bernatchez, Chantale, Han, Leng, Tsang, Yiu-Huen, Kong, Kathleen, Xu, Xiaoyan, Scott, Kenneth L., Singh-Jasuja, Harpreet, Lizee, Greg, Liang, Han, Weinschenk, Toni, Mills, Gordon B., Hwu, Patrick

Get full text

Whole-chromosome arm acquired uniparental disomy in cancer development is a consequence of isochromosome formation by Tuna, Musaffe, Amos, Christopher I., Mills, Gordon B.

Get full text

Assessing the clinical utility of cancer genomic and proteomic data across tumor types by Yuan, Yuan, Van Allen, Eliezer M, Omberg, Larsson, Wagle, Nikhil, Amin-Mansour, Ali, Sokolov, Artem, Byers, Lauren A, Xu, Yanxun, Hess, Kenneth R, Diao, Lixia, Han, Leng, Huang, Xuelin, Lawrence, Michael S, Weinstein, John N, Stuart, Josh M, Mills, Gordon B, Garraway, Levi A, Margolin, Adam A, Getz, Gad, Liang, Han

Get full text

PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models by Park, Ki Cheong, Kim, Jung Min, Kim, Sang Yong, Kim, Seok-Mo, Lim, Jin Hong, Kim, Min Ki, Fang, Sungsoon, Kim, Yonjung, Mills, Gordon B, Noh, Sung Hoon, Cheong, Jae-Ho

Get full text

Precision oncology for breast cancer through clinical trials by Blucher, Aurora S., Mills, Gordon B., Tsang, Yiu Huen

Get full text

Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA by Sasaki, Noriyuki, Iwaya, Takeshi, Chiba, Takehiro, Fujita, Masashi, Ju, Zhenlin, Endo, Fumitaka, Yaegashi, Mizunori, Hachiya, Tsuyoshi, Sugimoto, Ryo, Sugai, Tamotsu, Siwak, Doris R, Liotta, Lance A, Lu, Yiling, Mills, Gordon B, Nakagawa, Hidewaki, Nishizuka, Satoshi S

Get full text

Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network Analysis by LADEVAIA, Sergio, YILING LU, MORALES, Fabiana C, MILLS, Gordon B, RAM, Prahlad T

Get full text

ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS by Alexander, Angela, Cai, Sheng-Li, Kim, Jinhee, Nanez, Adrian, Sahin, Mustafa, MacLean, Kirsteen H, Inoki, Ken, Guan, Kun-Liang, Shen, Jianjun, Person, Maria D, Kusewitt, Donna, Mills, Gordon B, Kastan, Michael B, Walker, Cheryl Lyn

Get full text

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer by Garrido-Castro, Ana C, Saura, Cristina, Barroso-Sousa, Romualdo, Guo, Hao, Ciruelos, Eva, Bermejo, Begoña, Gavilá, Joaquin, Serra, Violeta, Prat, Aleix, Paré, Laia, Céliz, Pamela, Villagrasa, Patricia, Li, Yisheng, Savoie, Jennifer, Xu, Zhan, Arteaga, Carlos L, Krop, Ian E, Solit, David B, Mills, Gordon B, Cantley, Lewis C, Winer, Eric P, Lin, Nancy U, Rodon, Jordi

Get full text

Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors by Wang, Lulu, Yang, Lin, Wang, Chen, Zhao, Wei, Ju, Zhenlin, Zhang, Wei, Shen, Jianfeng, Peng, Yang, An, Clemens, Luu, Yen T, Song, Shumei, Yap, Timothy A, Ajani, Jaffer A, Mills, Gordon B, Shen, Xuetong, Peng, Guang

Get full text

Expression of chimeric antigen receptor therapy targets detected by single-cell sequencing of normal cells may contribute to off-tumor toxicity by Jing, Ying, Liu, Yuan, Li, Qiang, Ye, Youqiong, Diao, Lixia, Huang, Yun, Zhou, Yubin, Green, Michael R., Mills, Gordon B., Han, Leng

Get full text

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models by XIAOMEI ZHANG, CLAERHOUT, Sofie, HELEN WONG, FUQUA, Suzanne W, CONTRERAS, Alejandro, GUTIERREZ, Carolina, JIAN HUANG, SUFENG MAO, PAVLICK, Anne C, FROEHLICH, Amber M, WU, Meng-Fen, TSIMELZON, Anna, PRATT, Aleix, HILSENBECK, Susan G, CHEN, Edward S, ZULOAGA, Pavel, SHAW, Chad A, RIMAWI, Mothaffar F, PEROU, Charles M, MILLS, Gordon B, CHANG, Jenny C, LEWIS, Michael T, DOBROLECKI, Lacey E, PETROVIC, Ivana, QING LAI, LANDIS, Melissa D, WIECHMANN, Lisa, SCHIFF, Rachel, GIULIANO, Mario

Get full text

Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer by Wang, Yumeng, Xu, Xiaoyan, Maglic, Dejan, Dill, Michael T, Mojumdar, Kamalika, Ng, Patrick Kwok-Shing, Jeong, Kang Jin, Tsang, Yiu Huen, Moreno, Daniela, Bhavana, Venkata Hemanjani, Peng, Xinxin, Ge, Zhongqi, Chen, Hu, Li, Jun, Chen, Zhongyuan, Zhang, Huiwen, Han, Leng, Du, Di, Creighton, Chad J, Mills, Gordon B, Camargo, Fernando, Liang, Han

Get full text

Naturally Occurring Neomorphic PIK3R1 Mutations Activate the MAPK Pathway, Dictating Therapeutic Response to MAPK Pathway Inhibitors by Cheung, Lydia W.T., Yu, Shuangxing, Zhang, Dong, Li, Jie, Ng, Patrick K.S., Panupinthu, Nattapon, Mitra, Shreya, Ju, Zhenlin, Yu, Qinghua, Liang, Han, Hawke, David H., Lu, Yiling, Broaddus, Russell R., Mills, Gordon B.

Get full text